Market Research Logo

Iraq Pharmaceuticals and Healthcare Report Q4 2017

Iraq Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Iraq's demographic trends, as well as the high and underlying demand for health care, will support strong growth of pharmaceutical spending over the forecast period, based largely on volume drivers. Despite the slightly improved economic outlook, Iraq's operating environment will face myriad of challenges, including structural impediments in the near term, weighing on the health system development potential. Given limited local drug manufacturing capacity, drug imports will continue to cover most of the domestic demand.

Headline Expenditure Projections

Pharmaceuticals: IQD2.12trn (USD1.79bn) in 2016 to IQD2.22trn (USD1.88bn) in 2017; +4.9% in local currency and +4.8% in US dollar terms. Forecast in line with last quarter.

Healthcare: IQD13.39trn (USD11.33bn) in 2016 to IQD14.13trn (USD11.94bn) in 2017; +5.5% in local currency and +5.4% in US dollar terms. Forecast in line with last quarter.

Latest Updates

As of July 2017, Iraq has one of the highest rates of Tuberculosis (TB) in the region, with over 15,000 people affected in the country annually, says a report by the Iraqi government and the United Nations.


BMI Industry View
Table: Headline Pharmaceuticals And Healthcare Forecasts (2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Iraq 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Iraq 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Iraq 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Iraq 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Iraq 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Iraq 2015-2021)
Industry Risk/Reward Index
MENA Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Review
Regulatory Regime
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Iraq 2011-2016)
Table: Healthcare Personnel (Iraq 2011-2016)
Table: Healthcare Activity (Iraq 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Awamedica
Samarra
State Company For Drugs Industries And Medical Appliances (Ninewa)
Demographic Forecast
Table: Population Headline Indicators (Iraq 1990-2025)
Table: Key Population Ratios (Iraq 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Iraq 1990-2025)
Table: Population By Age Group (Iraq 1990-2025)
Table: Population By Age Group % (Iraq 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report